Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v11-EN
Language French English
Date Updated 2017-08-25 2017-08-25
Drug Identification Number 02163683 02163683
Brand name CEFZIL POWDER FOR ORAL SUSPENSION-250MG/5ML CEFZIL POWDER FOR ORAL SUSPENSION-250MG/5ML
Common or Proper name Cefprozil Cefprozil
Company Name BRISTOL-MYERS SQUIBB CANADA BRISTOL-MYERS SQUIBB CANADA
Ingredients CEFPROZIL CEFPROZIL
Strength(s) 250mg 250mg
Dosage form(s) Powder for solution Powder for solution
Route of administration oral oral
Packaging size 1 BTL x 100ml 1 BTL x 100ml
ATC code J01DC J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2017-08-31 2017-08-31
Actual discontinuation date 2017-08-23 2017-08-23
Remaining supply date 2017-08-23 2017-08-23
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments